EU's COVID-19 vaccine rollout suffering shortages and delays, says BioTech CEO
EU's COVID-19 vaccine rollout suffering shortages and delays, says BioTech CEO

The shortage is being partly blamed on the fact that the European Medicines Agency is yet to approve the Moderna and Oxford-Astrazeneca vaccines.